EKF Diagnostics (LON:EKF) Stock Price Up 27.3% - Here's Why

EKF Diagnostics Holdings plc (LON:EKF - Get Free Report) traded up 27.3% during mid-day trading on Thursday . The stock traded as high as GBX 26.90 ($0.36) and last traded at GBX 25.20 ($0.34). 2,253,335 shares were traded during trading, an increase of 353% from the average session volume of 497,132 shares. The stock had previously closed at GBX 19.80 ($0.26).

EKF Diagnostics Stock Up 4.4%

The stock has a market capitalization of £116.01 million, a P/E ratio of 24.29 and a beta of 0.57. The stock has a 50 day moving average price of GBX 21.44 and a 200-day moving average price of GBX 23.85. The company has a debt-to-equity ratio of 0.34, a current ratio of 4.60 and a quick ratio of 1.77.

EKF Diagnostics (LON:EKF - Get Free Report) last posted its quarterly earnings results on Tuesday, March 25th. The company reported GBX 1.38 ($0.02) earnings per share (EPS) for the quarter. EKF Diagnostics had a return on equity of 7.03% and a net margin of 9.37%. As a group, research analysts expect that EKF Diagnostics Holdings plc will post 2.2987842 EPS for the current fiscal year.

Insider Transactions at EKF Diagnostics

In other EKF Diagnostics news, insider Gavin T. Jones purchased 50,000 shares of EKF Diagnostics stock in a transaction that occurred on Tuesday, March 25th. The shares were bought at an average price of GBX 22 ($0.29) per share, for a total transaction of £11,000 ($14,692.13). Company insiders own 5.24% of the company's stock.

EKF Diagnostics Company Profile

EKF is an AIM-listed global diagnostics business focussed on: ● Point-of-Care analysers in the key areas of Hematology and Diabetes ● Life Sciences services provide specialist manufacture of enzymes and custom products for use in diagnostic, food and industrial applications. EKF has headquarters in Penarth (near Cardiff) and operates five manufacturing sites across the US and Germany, selling into over 120 countries world-wide.